Blue Shield of California is reducing its staffing by 140 positions, or about 2% of the workforce.
The National Association of ACOs is asking for changes to the information blocking rule prohibiting participation in the Medicare Shared Savings Program if the ACO or its clinicians for noncompliance.
Note: Andreessen Horowitz says views expressed by its employees are their own and should not be taken as investment advice. More details at https://a16z.com/disclosures/
A trend from 2023 that appears determined to persist into the new year is cybersecurity risk, as a Missouri hospital’s computer systems were disrupted at the end of December, forcing the facility to take its computer systems offline. Liberty Hospital became aware of the disruption on December 19, at which time it took its entire […]
Interest rates are expected to fall in 2024, changing the healthcare investment landscape moving into the new year, according to Bret Schiller, head of Healthcare Corporate Client Banking & Specialized Industries at J.P. Morgan. “We think that rate cuts will start by the second, third quarter,” Schiller said.
The year may be new, but the concerns about COVID-19 are old: A new study in JAMA shows that people who have been hospitalized with COVID-19 perform worse on cognitive and neurological tests, suggesting impaired brain function.
The Trusted Exchange Framework and Common Agreement is now live, but the challenge is FHIR in TEFCA, says Don Rucker, chief strategy officer for 1upHealth and former national coordinator for Health IT at HHS.
The Department of Justice wants Humana’s complaint against the Department of Health and Human Services thrown out, but it wants the decision made in a court other than the one where the case was filed.
Rite Aid Corporation has reached a settlement with the Federal Trade Commission regarding the company’s use of AI facial recognition technology to prevent retail theft. Rite Aid said it disagrees with the allegations related to the facial recognition technology.
FDA regulatory attorney Brigid Bondoc, partner and life sciences attorney at Morrison Foerster, helps companies control their risk.